Theranos failed a second major U.S. regulatory inspection of its laboratory facilities, people familiar with the situation said, a setback the Silicon Valley blood-testing firm hasn’t disclosed to investors or patients.
from WSJ.com: US Business http://ift.tt/2k2Xagj
via IFTTT
No comments:
Post a Comment